Business
NED Appointment and Committee Changes
Dr. Martens plc announced the appointment of Melanie Richards CBE as an Independent Non-Executive Director, effective from the conclusion of the 2026 AGM on July 15, 2026, filling a vacancy left by Lynne Weedall. Richards will also assume the roles of Senior Independent Director and Chair of the Nomination Committee, and join the Audit and Risk and Remuneration Committees. Concurrently, Andrew Harrison will become Chair of the Remuneration Committee. These changes are intended to strengthen the Board's strategic direction and commercial performance. Disclaimer*
About this update from Dr. Martens Plc
1 July 2026 Dr. Martens plc APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMMITTEE CHANGES Dr. Martens plc ('Dr. Martens' or 'the Company') is pleased to announce the appointment of Melanie Richards CBE as an Independent Non-Executive Director of the Company, with effect from the conclusion of the Company's Annual General Meeting on 15 July 2026 ('the 2026 AGM'). This follows the Company's prior announcement on 27 May 2026 that Lynne Weedall would step down from the Board following the 2026 AGM and that a further update on Board succession would be made in due course. Melanie is former Deputy Chair of KPMG UK and currently serves as Chair of Azets and as a Non-Executive Director of Morgan Stanley & Co. International and HKA Global. She brings broad-based executive, commercial, financial and capital markets experience, together with significant board and advisory experience and a strong track record of contributing to strategic direction and commercial performance in complex organisations. Upon joining the Board, Melanie will be appointed Senior Independent Director and Chair of the Nomination Committee, and will also become a member of the Audit and Risk Committee and the Remuneration Committee, while Andrew Harrison, Independent Non-Executive Director, will be appointed Chair of the Remuneration Committee. These appointments will take effect from the conclusion of the 2026 AGM. Paul Mason, Chairman, said: 'We are delighted to welcome Melanie to the Board. Her extensive board experience, together with her valuable financial and commercial insight and fresh perspective, will strengthen the Board as we continue to execute our consumer-first strategy and deliver long-term sustainable growth. We are pleased that Andrew brings both continuity and experience, as he becomes Chair of the Remuneration Committee'. NOTES 1. This announcement is made pursuant to UK Listing Rule 6.4.6R. 2. The Company confirms that there is no further information that is required to be disclosed pursuant to UK Listing Rule 6.4.8R. Enquiries Investors and analysts &n...